<?xml version="1.0" encoding="UTF-8"?>
<ack id="ack0001">
 <sec id="sec0017">
  <title>Funding</title>
  <p id="para0043">This paper was sponsored by the Immuno-Gene Therapy of the International Society for Cell and Gene Therapy. V.B. is supported by Fondazione Cariverona (ENACT project) and Fondazione TIM. M.C. and J.J.B. acknowledge support of the NIH Cancer Center Support Grant P30 CA008748.</p>
 </sec>
 <sec id="sec0018">
  <title>Author Contributions</title>
  <p id="para0044">Conception and design of the study: MC, JJB, PH. Analysis and interpretation of data: MC, PH, JJB, BL, RC, PR, VB, DW, CB. Drafting or revising the manuscript: MC, PH, JJB, BL, RC, PR, VB, DW, CB. All authors have approved the final article.</p>
 </sec>
 <sec id="sec0019">
  <title>Acknowledgments</title>
  <p id="para0045">The authors thank the Immuno-Gene Therapy Committee of the International Society for Cell and Gene Therapy (ISCT) for sponsoring this article. We also recognize Dr. Alexey Bersenev for providing the open-access COVID-19 clinical trial database.</p>
 </sec>
</ack>
